Polo-like kinase 1 inhibition as a new therapeutic modality in therapy of cholangiocarcinoma. [electronic resource]
Producer: 20111122Description: 3289-99 p. digitalISSN:- 1791-7530
- Cell Cycle -- drug effects
- Cell Cycle Proteins -- antagonists & inhibitors
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cholangiocarcinoma -- drug therapy
- Deoxycytidine -- analogs & derivatives
- Fluorouracil -- pharmacology
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Protein Kinase Inhibitors -- pharmacology
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Pteridines -- pharmacology
- Pyrimidines -- pharmacology
- Pyrroles -- pharmacology
- RNA, Messenger -- genetics
- Gemcitabine
- Polo-Like Kinase 1
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.